{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T13:56:06Z","timestamp":1768571766640,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"publisher","award":["CZ.02.2.69\/0.0\/0.0\/19_073\/0016935"],"award-info":[{"award-number":["CZ.02.2.69\/0.0\/0.0\/19_073\/0016935"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014809","name":"Technology Agency of the Czech Republic","doi-asserted-by":"publisher","award":["TJ04000443"],"award-info":[{"award-number":["TJ04000443"]}],"id":[{"id":"10.13039\/100014809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Czech Republic Ministry of Health","doi-asserted-by":"publisher","award":["NU22-05-00402"],"award-info":[{"award-number":["NU22-05-00402"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009553","name":"Agentura Pro Zdravotnick\u00fd V\u00fdzkum \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009553","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jaip.2022.10.046","type":"journal-article","created":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T18:05:55Z","timestamp":1668362755000},"page":"306-314.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical Outcomes, Immunogenicity, and Safety of BNT162b2 Vaccine in Primary Antibody Deficiency"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2105-3462","authenticated-orcid":false,"given":"Tomas","family":"Milota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jitka","family":"Smetanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aneta","family":"Skotnicova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Rataj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Lastovicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Zelena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzana","family":"Parackova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Fejtkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronika","family":"Kanderova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Fronkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katerina","family":"Rejlova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Sediva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Kalina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2022.10.046_bib2","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaci.2020.12.620","article-title":"COVID-19 in patients with primary and secondary immunodeficiency: the United Kingdom experience","volume":"147","author":"Shields","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.046_bib3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jaci.2020.09.010","article-title":"Coronavirus disease 2019 in patients with inborn errors of immunity: an international study","volume":"147","author":"Meyts","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.046_bib4","article-title":"Minor clinical impact of COVID-19 pandemic on patients with primary immunodeficiency in Israel","volume":"11","author":"Marcus","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2022.10.046_bib5","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2022.10.046_bib6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJMoa2116185","article-title":"Efficacy and safety of NVX-CoV2373 in adults in the United States and Mexico","volume":"386","author":"Dunkle","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2022.10.046_bib7","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2022.10.046_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2022.10.046_bib9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2022.10.046_bib10","doi-asserted-by":"crossref","first-page":"n1931","DOI":"10.1136\/bmj.n1931","article-title":"Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study","volume":"374","author":"Hippisley-Cox","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2022.10.046_bib11","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa2109730","article-title":"Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel","volume":"385","author":"Mevorach","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2022.10.046_bib12","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.jaip.2019.02.004","article-title":"The European Society for Immunodeficiencies (ESID) Registry Working Definitions for the Clinical Diagnosis of Inborn Errors of Immunity","volume":"7","author":"Seidel","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.10.046_bib13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International Consensus Document (ICON): common variable immunodeficiency disorders","volume":"4","author":"Bonilla","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.10.046_bib14","article-title":"Common variable immunodeficiency patients with a phenotypic profile of immunosenescence present with thrombocytopenia","volume":"7","author":"Stuchl\u00fd","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2022.10.046_bib15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jaip.2022.10.046_bib16","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3390\/diagnostics11040593","article-title":"Five commercial immunoassays for SARS-CoV-2 antibody determination and their comparison and correlation with the virus neutralization test","volume":"11","author":"\u0160im\u00e1nek","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jaip.2022.10.046_bib17","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1016\/S2665-9913(21)00393-3","article-title":"Humoral and cellular immune responses to mRNA COVID-19 vaccines in patients with axial spondyloarthritis treated with adalimumab or secukinumab","volume":"4","author":"Smetanova","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jaip.2022.10.046_bib18","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.healun.2021.05.004","article-title":"Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients","volume":"40","author":"Havlin","year":"2021","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jaip.2022.10.046_bib19","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/cyto.b.21348","article-title":"Appearance of cytomegalovirus-specific T-cells predicts fast resolution of viremia post hematopoietic stem cell transplantation","volume":"92","author":"Pel\u00e1k","year":"2017","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.jaip.2022.10.046_bib20","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.clim.2007.04.011","article-title":"Active vaccination in patients with common variable immunodeficiency (CVID)","volume":"124","author":"Goldacker","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.046_bib21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11882-017-0749-3","article-title":"Influenza vaccination in patients with common variable immunodeficiency (CVID)","volume":"17","author":"Mieves","year":"2017","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2022.10.046_bib22","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.jaip.2020.04.019","article-title":"Preserved cellular immunity upon influenza vaccination in most patients with common variable immunodeficiency","volume":"8","author":"Friedmann","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.10.046_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.727850","article-title":"Humoral and cellular response following vaccination with the BNT162b2 mRNA COVID-19 vaccine in patients affected by primary immunodeficiencies","volume":"12","author":"Amodio","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2022.10.046_bib24","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jaci.2021.05.029","article-title":"Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity","volume":"148","author":"Hagin","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.046_bib25","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.jaci.2021.08.016","article-title":"Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity","volume":"148","author":"Delmonte","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.046_bib26","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.jaci.2022.04.002","article-title":"Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity","volume":"149","author":"van Leeuwen","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.046_bib27","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2022.10.046_bib28","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/s41591-021-01540-1","article-title":"Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection","volume":"27","author":"Feng","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2022.10.046_bib29","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s10875-021-01174-5","article-title":"Immunogenicity of anti-SARS-CoV-2 vaccines in common variable immunodeficiency","volume":"42","author":"Arroyo-S\u00e1nchez","year":"2022","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.046_bib30","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s10875-022-01244-2","article-title":"Elevated CD21low B cell frequency is a marker of poor immunity to Pfizer-BioNTech BNT162b2 mRNA vaccine against SARS-CoV-2 in patients with common variable immunodeficiency","volume":"42","author":"Bergman","year":"2022","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.046_bib31","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/imr.12656","article-title":"Immunological memories of the bone marrow","volume":"283","author":"Chang","year":"2018","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaip.2022.10.046_bib32","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3390\/cells10061508","article-title":"The bone marrow as sanctuary for plasma cells and memory T-cells: implications for adaptive immunity and vaccinology","volume":"10","author":"Slamanig","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jaip.2022.10.046_bib33","doi-asserted-by":"crossref","DOI":"10.1172\/JCI155499","article-title":"Difference in sensitivity between SARS-CoV-2-specific T cell assays in patients with underlying conditions","volume":"131","author":"de Vries","year":"2021","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2022.10.046_bib34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cytogfr.2013.04.003","article-title":"The BAFF\/APRIL system: emerging functions beyond B cell biology and autoimmunity","volume":"24","author":"Vincent","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jaip.2022.10.046_bib35","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s10875-011-9602-y","article-title":"TLR-mediated B cell defects and IFN-\u03b1 in common variable immunodeficiency","volume":"32","author":"Yu","year":"2012","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.046_bib36","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/s41591-022-01699-1","article-title":"Effectiveness of COVID-19 booster vaccines against COVID-19 related symptoms, hospitalization and death in England","volume":"28","author":"Andrews","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2022.10.046_bib37","article-title":"Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: a retrospective cohort study","volume":"9","author":"Tartof","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.jaip.2022.10.046_bib38","doi-asserted-by":"crossref","first-page":"e384","DOI":"10.1056\/NEJMoa2114583","article-title":"Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months","volume":"385","author":"Levin","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2022.10.046_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.839922","article-title":"Persistence of immune response in health care workers after two doses BNT162b2 in a longitudinal observational study","volume":"13","author":"Herzberg","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2022.10.046_bib40","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","article-title":"Covid-19 vaccine effectiveness against the Omicron (B.1.1.529) variant","volume":"386","author":"Andrews","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2022.10.046_bib41","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(21)02249-2","article-title":"Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study","volume":"398","author":"Barda","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2022.10.046_bib42","doi-asserted-by":"crossref","first-page":"e775","DOI":"10.1016\/S2665-9913(22)00216-8","article-title":"COVID-19 vaccine effectiveness against omicron (B.1.1.529) variant infection and hospitalisation in patients taking immunosuppressive medications: a retrospective cohort study","volume":"4","author":"Risk","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jaip.2022.10.046_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104066","article-title":"COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents","volume":"80","author":"Canaday","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jaip.2022.10.046_bib44","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa2208343","article-title":"A\u00a0bivalent Omicron-containing booster vaccine against Covid-19","volume":"387","author":"Chalkias","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2022.10.046_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abn8014","article-title":"Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants","volume":"7","author":"Bates","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaip.2022.10.046_bib46","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S1473-3099(22)00640-5","article-title":"Hybrid immunity and strategies for COVID-19 vaccination","volume":"23","author":"Hui","year":"2023","journal-title":"Lancet Infect Dis"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822011916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822011916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:38:20Z","timestamp":1761975500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219822011916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2213219822011916"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2022.10.046","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Outcomes, Immunogenicity, and Safety of BNT162b2 Vaccine in Primary Antibody Deficiency","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2022.10.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}